Sotac Pharmaceuticals Stock

Sotac Pharmaceuticals Equity

The The Equity of Sotac Pharmaceuticals (SOTAC.NS) as of Sep 5, 2026 is 532.52 M INR. In the previous year, The Equity was 453.00 M INR — a change of 17.55% (higher).

Equity

532.52 MINR

YoY

17.55%

Last updated:

In 2026, Sotac Pharmaceuticals's equity was 532.52 M INR, a 17.55% increase from the 453.00 M INR equity in the previous year.

The Sotac Pharmaceuticals Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
30.57 M INR
Jan 1, 2021
24.94 M INR
Jan 1, 2022
66.22 M INR
Jan 1, 2024
453.00 M INR
Jan 1, 2025
532.52 M INR
The Sotac Pharmaceuticals Equity history
YEAREquityYoY
532.52 MINR+17.55%
453.00 MINR+584.09%
66.22 MINR+165.56%
24.94 MINR-18.44%
30.57 MINR—
Access this data via the Eulerpool API
Get Free API Key

Sotac Pharmaceuticals Stock analysis

What does Sotac Pharmaceuticals do? Sotac Pharmaceuticals is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Sotac Pharmaceuticals's Equity

Sotac Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sotac Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sotac Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sotac Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sotac Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sotac Pharmaceuticals stock

The Equity of Sotac Pharmaceuticals is 532.52 M INR in 2026.

The Equity of Sotac Pharmaceuticals changed from 453.00 M INR to 532.52 M INR, representing a 17.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Sotac Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Sotac Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Sotac Pharmaceuticals

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Sotac Pharmaceuticals